Table 3.

Selected ColoCare publications

Manuscript titleYearFull author blockJournalPMID/PMCID
Altered RECQ helicase expression in sporadic primary colorectal cancers.2013Lao VV, Welsch P, Luo Y, Carter KT, Dzieciatkowski S, Dintzis S, Meza J, Sarvetnick NE, Monnat RJ, Loeb LA, Grady WMTranslational Oncology23908689/3730021
NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer.2013Luo Y, Kaz AM, Kanngurn S, Welsch P, Morris SM, Wang J, Lutterbaugh JD, Markowitz SD, Grady WMPLoS Genetics23874207/3708790
RET is a potential tumor suppressor gene in colorectal cancer.2013Luo Y, Tsuchiya KD, Il Park D, Fausel R, Dannagurn S, Welsch P, Dzieciatkowski S, Wang J, Grady WMOncogene22751117/3465636
Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue.2013Sherwood A, Emerson R, Scherer D, Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D, Schirmacher P, Herpel E, Kloor M, Ulrich A, Schneider M, Ulrich C, Robins HCancer Immunotherapy and Immunology23771160/5714563
Plasma 25-hydroxyvitamin D3, folate and vitamin B12 biomarkers among international colorectal cancer patients: a pilot study.2013Ulrich CM, Toriola AT, Siegel E, Brenner H, Chang-Claude J, Abbenhardt C, Kotzmann J, Song X, Owen RW, Hoffmeister M, Becher H, Shibata D, Vickers K, Rush SK, Makar K, Würtele G, Haubner R, Sellers TA, Grady WJournal of Nutritional Science25191595/4153124
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.2014Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WMGastroenterology24793120/4107146
Suitability of circulating miRNAs as potential prognostic markers in colorectal cancer.2014Ristau J, Staffa J, Schrotz-King P, Gigic B, Makar KW, Hoffmeister M, Brenner H, Ulrich A, Schneider M, Ulrich CM, Habermann NCancer Epidemiology Biomarkers and Prevention25472670/5699859
Potential of fecal microbiota for early-stage detection of colorectal cancer.2014Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Amiot A, Brunetti F, Costea PI, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Staffa J, Tournigand C, Van Nhieu JT, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork PMolecular Systems Biology25432777/4299606
Changes in urinary metabolic profiles of colorectal cancer patients enrolled in a prospective cohort study (ColoCare).2015Liesenfeld D, Habermann N, Toth R, Owen R, Frei E, Böhm J, Schrotz-King P, Klika K, Ulrich CMMetabolomics29250455/5730072
Repeat physical activity measurement by accelerometry among colorectal cancer patients-feasibility and minimal number of days of monitoring.2015Skender S, Schrotz-King P, Boehm J, Abbenhardt C, Gigic B, Chang-Claude J, Siegel EM, Steindorf K, Ulrich CMBMC Research Notes26048683/4456792
Methylight digital droplet PCR for detection and absolute quantification of infrequent methylated alleles.2015Yu M, Carter KT, Makar KW, Vickers K, Ulrich CM, Schoen RE, Markowitz SD, Grady WMEpigenetics26186366/4623055
Discovery of novel plasma proteins as biomarkers for the development of incisional hernias after midline incision in patients with colorectal cancer: The ColoCare study.2016Böhm J, Pianka F, Stüttgen N, Rho J, Gigic B, Zhang Y, Habermann N, Schrotz-King P, Abbenhardt-Martin C, Zielske L, Lampe PD, Ulrich A, Diener MK, Ulrich CMSurgery27745870/5560863
Genome-wide interaction analyses between genetic variants and alcohol consumption and smoking for risk of colorectal cancer.2016Gong J, Hutter CM, Newcomb PA, Ulrich CM, Bien SA, Campbell PT, Baron JA, Berndt SI, Bezieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Du M, Duggan D, Figueiredo JC, Schrotz-King P, Seminara D, Slattery ML, Thibodeau SN, Thornquist M, Toth R, Wallace R, White E, Jiao S, Lemire M, Hsu L, Peters U; CCFR and GECCOPLoS Genetics27723779/5065124
CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients.2016Nattenmuller J, Hoegenauer H, Boehm J, Scherer D, Paskow M, Gigic B, Schrotz-King P, Grenacher L, Ulrich CM, Kauczor HUEuropean Radiology26852215/5587125
Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.2017Barrow TM, Klett H, Toth R, Bohm J, Gigic B, Habermann N, Scherer D, Schrotz-King P, Skender S, Abbenhardt-Martin C, Zielskie L, Schneider M, Ulrich A, Schirmacher P, Herpel E, Brenner H, Busch H, Boerries M, Ulrich CM, Michels KBJournal of Pathology28791728/5647242
Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare Study.2017Liesenfeld DB, Grapov D, Fahrmann JF, Salou M, Scherer D, Toth R, Habermann N, Böhm J, Schrotz-King P, Gigic B, Schneider M, Ulrich A, Herpel E, Schirmacher P, Fiehn O, Lampe JW, Ulrich CMAmerican Journal of Clinical Nutrition26156741/4515859
Plasma 25-hydroxyvitamin D3 levels in colorectal cancer patients and associations with physical activity.2017Skender S, Böhm J, Schrotz-King P, Chang-Claude J, Siegel EM, Steindorf K, Owen RW, Ose J, Hoffmeister M, Brenner H, Ulrich CMNutrition and Cancer: An International Journal28094599/5587127
Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.2017Yuan Z, Baker K, Redman MW, Wang L, Adams SV, Yu M, Dickinson B, Makar K, Ulrich N, Böhm J, Wurscher M, Westerhoff M, Medwell S, Moonka R, Sinanan M, Fichera A, Vickers K, Grady WMBritish Journal of Cancer28809863/5674097
Quantitative assessment of visceral obesity and postoperative colon cancer outcomes.2017Ozoya OO, Siegel EM, Srikumar T, Bloomer AM, DeRenzis A, Shibata DJournal of Gastrointestinal Surgery28101721/5560865
Associations between dietary patterns and longitudinal quality of life changes in colorectal cancer patients: the ColoCare Study.2017Gigic B, Boeing H, Toth T, Böhm J, Habermann N, Scherer D, Schrotz-King P, Abbenhardt-Martin C, Skender S, Brenner H, Chang-Claude J, Hoffmeister M, Syrjala S, Jacobsen PB, Schneider M, Ulrich A, Ulrich CMNutrition and Cancer: An International Journal1397707/5867188
Associations of branched-chain amino acids with parameters of energy balance and survival in colorectal cancer patients: Results from the ColoCare Study.2018Delphan M, Lin T, Liesenfeld DB, Nattenmüller J, Böhm JT, Gigic B, Habermann N, Zielske L, Schrotz-King P, Schneider M, Ulrich A, Kauczor HU, Ulrich CM, Ose JMetabolomics29706852/5922458
Robust prediction of gene regulation in colorectal cancer tissues from DNA methylation profiles.2018Klett H, Balavarca Y, Toth R, Gigic B, Habermann N. Scherer D, Schrotz-King P, Ulrich A, Schirmacher P, Herpel E, Brenner H, Ulrich CM, Michels KB, Busch H, Boerries MEpigenetics29697014/6140810
Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study.2018Himbert C, Ose J, Nattenmueller J, Warby CA, Holowatyj AN, Böhm J, Lin T, Haffa M, Gigic B, Hardikar S, Scherer D, Zielske L, Schrotz-King P, Koelsch T, Siegel EM, Shibata D, Ulrich A, Schneider M, Hursting SD, Kauczor HU, Ulrich CMCancer Epidemiology Biomarkers and Prevention30333223/6324954
Implications of epigenetic drift in colorectal neoplasia2018Luebeck G, Hazelton W, Curtius K, Maden S, Yu M, Carter K, Burke W, Lampe P, Li C, Ulrich CM, Newcomb P, Westerhoff M, Kaz K, Luo Y, Inadomi J, Grady WCancer Research30291105/6359943
Rare loss of function variants in candidate genes and risk of colorectal cancer.2018Rosenthal EA, Shirts BH, Amendola LM, Horike-Pyne M, Robertson PD, Hisama FM, Bennett RL, Dorschner MO, Nickerson, DA, Stanaway IB, Nassir, R, Vickers KA, Li C, Grady WM, Peters U, Jarvik GP on behalf of the NHLBI GO Exome Sequencing ProjectHuman Genetics30267214/6283057